Navigation Links
Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
Date:6/16/2008

Cato Research Signed as Strategic Partner for the Phase 3 Program

LA JOLLA, Calif., June 16 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company developing non-invasive, topically administered medications, today announced the initiation of its Phase 3 clinical program for Ketotransdel(TM), its novel topical cream based non-steroidal anti-inflammatory drug ("NSAID") for pain. The Company has engaged Cato Research Ltd., a global contract research organization ("CRO"), as a strategic partner and as the CRO to conduct the Phase 3 clinical program.

The Company's randomized, double-blind, placebo controlled Phase 3 trial will evaluate the efficacy and safety of Ketotransdel(TM) for the topical treatment of acute pain from soft tissue injuries. Clinical sites are planned throughout the United States and potentially other regions, including Canada. The Company expects that Ketotransdel(TM), if approved by the U.S. Food and Drug Administration, could become the first topical NSAID cream product in the United States for acute pain management. The drug could address what the Company believes is a significant unmet medical need for patients and physicians seeking a potentially safer alternative to existing pain management approaches, such as oral NSAIDs.

"Advancing Ketotransdel(TM) into Phase 3 clinical studies is a significant milestone for our Company. Our top priority is to execute our clinical program as planned," said Dr. Juliet Singh, President and Chief Executive Officer of Transdel Pharmaceuticals. "For the conduct of the clinical trial we carefully evaluated only select top level CROs with extensive experience in the relevant pain area. We selected Cato Research not only due to their relationship as a strategic partner with us, but because of their cost efficient approach to the clinical program, expertise in the pain space and our direct access to their senior executive man
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
2. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
3. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
4. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
5. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
6. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
7. Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors
8. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
9. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
10. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
11. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2008)...TOWN, Pa., Aug. 18 /PRNewswire-USNewswire/ -- Due ...-infected mosquitoes in,southeastern Pennsylvania,...s county partners will be stepping up efforts this... -- or are most likely to carry -- the virus., Wh... been confirmed,this year (a 27-year-old Montgomer...
(Date:8/18/2008)..., Aug. 18 /PRNewswire-USNewswire/ -- Boston Univer...t of the Center for Human Genetics, Inc.,("CHG") a...ston University,announced that CHG will no longer...d to Athena Diagnostics, Inc., These patented tes...s,related to A1555G or Connexin 26 mutations, deve...
(Date:8/18/2008)...LEM, Israel, August 18 /- O...p://www.oramed.com ), a developer,of oral delivery...led "Open,Label Study to Assess the Safety, Pharma...Oral Insulin Formulations in Healthy,Subjects," ha...h Annual,Meeting of the European Association for t...
(Date:8/18/2008)...y Leader with Strong Clinical Research Relationshi...ganizations to Lead Commercialization, SANTA CLAR...rdio, Inc.,(OTC Bulletin Board: NWCI) a cardiac d...at Vincent W. Renz has joined NewCardio as its pre...cialization effort, to include,business developmen...
Breaking Medicine Technology:Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4VA Deploying Assessment Team to Marion Medical Center 5616 1VA Deploying Assessment Team to Marion Medical Center 5616 2US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 1US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 2US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 3US FDA approves ABILIFY for adolescent patients with schizophrenia 5611 4Energy Drinks Could Pose Blood Pressure Risks 5609 1Energy Drinks Could Pose Blood Pressure Risks 5609 2PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 1PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 2PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 3PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 4PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 5PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 6PharmAthene and Medarex Announce Additional 240 8 Million U S Government Appropriation for Continued Development of Anthrax Therapeutic Valortim 28T 5605 7
...14, 2007 - NanoViricides,Inc. (Pink Sheets: NNVC)...ies against rabies that were presented along with ...de 2 H5N1 virus at,the 23rd Annual Symposium of th...mpa, FL, on Wednesday, May 2. (Pan American Societ... Symposium), The animal studies against rabies wer...
...- SIGA Technologies, Inc.,(NASDAQ: SIGA) announced...t guinea pig trial of its lead Lassa fever virus d...fety Level 4 conditions at,the U.S. Army Medical R...) by Dr. Kathleen Cashman under the supervision of...s hemorrhagic fever,viruses at USAMRIID for over 1...
Other Medicine Technology:Global Rabies Treatment May be Possible with NanoViricides Drugs 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...esearchers from the Autonomous University of Tamau...sal allergies//, bottle-feeding, thumb-sucking and... birth, even if it is for 4 months, could throw te...esearchers are armed to the teeth with evidence ga...
...rol software has been developed by scientists from...) and Siemens Medical Solutions //that facilitates...n using the internet by an off-site imaging expert...ote scans were better in quality than the onsite s...
...en have been found to be more irritable than their...cted by the Sleep Council in Britain. //The study ...ey woke up and they remained in that state of mind...% of the women were in a bad temper while waking u...
...arch suggests that children of couples having fert...ditions like autism and cerebral palsy. // Health...couples to conceive in the first place is probably...s, according to scientists. In addition fertility ...
Other Medicine News:Health News:Risk of autism Linked to Fertility Problems 2
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: